Using 3D ultrasound to map vascular problems in people with PAD and related wounds

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

PIUR Infinity tUS provides rapid, noninvasive 3D imaging of blood vessels to visualize areas of vascular insufficiency. The study uses this imaging to create educational visuals that accompany standard ultrasound studies and patient portals. It aims to improve patient understanding and potentially streamline referrals by reducing the need for additional imaging modalities. The trial is conducted at the Northwell Health Comprehensive Wound Center and focuses on adults with suspected vascular insufficiency undergoing scheduled ultrasound evaluation.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age 18 years of age or older
* Suspected vascular insufficiency that requires ultrasound evaluation
* Subject is able to sign a consent form
* Scheduled ultrasound testing at the wound center to evaluate vasculature

Exclusion Criteria:

* Younger than 18 years old
* Subject is not scheduled to have ultrasound testing at the wound center
* Subject is unable to or refuses to consent to participate

Where it's running

• Northwell Health Comprehensive Wound Center
  Lake Success, New York, United States Recruiting

Study contacts

• Principal investigator: Alisha Oropallo, MD — Northwell Health Comprehensive Wound Healing & Hyperbaric Center
• Study coordinator: Alisha Oropallo, MD
• Email: aoropallo@northwell.edu
• Phone: 516-233-3780

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients

  This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.

  Recruiting at 3 sites Phase 3 Pulmovant, Inc. · Kissimmee, Florida and 2 other locations · NCT07816185

• Prevalence of PAD in Patients With Surgically Treated Lumbar Spinal Stenosis

  This study tests how common peripheral artery disease is in people who have lumbar spinal stenosis and are being considered for, or have had, surgery.

  Recruiting Rennes University Hospital · Lille and 2 other locations · NCT07469020

• Road-mapping versus ultrasound guidance for retrograde arterial puncture during angioplasty

  This trial will test whether using road mapping or ultrasound to guide retrograde arterial puncture works better and is safer for adults with critical limb-threatening ischemia who need retrograde access during angioplasty.

  Recruiting Sohag University · Sohag · NCT07427108

• Mosliciguat added to inhaled treprostinil for pulmonary hypertension from ILD

  This trial tests whether adding inhaled mosliciguat to your inhaled treprostinil is safe and tolerable for people with pulmonary hypertension caused by interstitial lung disease.

  Recruiting at 13 sites Phase 2 Pulmovant, Inc. · Santa Barbara, California and 12 other locations · NCT07333183

• Coronary CT angiography–guided calcium modification during PCI for calcified coronary artery disease

  This study will see if using CT angiography to plan calcium treatment before stenting helps people with flow-limiting, calcified coronary artery disease have better stent results and faster procedures compared with the usual ultrasound-guided PCI while keeping similar safety.

  Recruiting at 10 sites Fundación EPIC · Boston, Massachusetts and 14 other locations · NCT07286578

• Freesolve resorbable magnesium scaffold vs. Xience stent for up to two new heart artery lesions

  This trial tests whether the Freesolve resorbable magnesium scaffold works as well as the Xience drug-eluting stent for treating up to two new coronary artery lesions in adults.

  Recruiting at 3 sites Teleflex · Washington D.C., District of Columbia and 2 other locations · NCT07258290

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.